Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban in chronic heart failure with coronary artery disease
CTR20140640Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rivaroxaban in chronic heart failure (CHF), coronary arteriosclerosis, sponsored by Bayer. Started Dec 2014; status: completed.
02
Drugs
rivaroxaban
03
Conditions
chronic heart failure (CHF)coronary arteriosclerosis
Beyond the preview
Go deeper on CTR20140640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140640.